To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effects of dexmedetomidine on pharyngeal swallowing and esophageal motility: A double-blind randomized cross-over study in healthy volunteers
Örebro University, School of Medical Sciences. Department of Anesthesiology and Intensive Care, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID iD: 0000-0002-9878-1735
College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland; Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, Turku, Finland.
Show others and affiliations
2023 (English)In: Neurogastroenterology and Motility, ISSN 1350-1925, E-ISSN 1365-2982, Vol. 35, no 1, article id e14501Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Sedative agents increase the risk of pulmonary aspiration, where an intact swallowing function is an important defense mechanism. Dexmedetomidine is an α2 -adrenoceptor agonist widely used during procedural sedation due to beneficial properties with minimal respiratory effects. The effects of dexmedetomidine on pharyngeal swallowing and esophageal motility are not known in detail.

METHODS: To determine the effects of dexmedetomidine on pharyngeal swallowing and esophageal motility, nineteen volunteers were included in this double-blinded, randomized placebo-controlled cross-over study. Study participants received target-controlled dexmedetomidine and placebo infusions. Recordings of pressure and impedance data were acquired using a manometry and impedance solid-state catheter. Data were analyzed from three bolus swallows series: baseline, during dexmedetomidine/placebo infusion at target plasma concentrations 0.6 ng ml-1 and 1.2 ng ml-1 . Subjective swallowing difficulties were also recorded.

KEY RESULTS: On pharyngeal swallowing, dexmedetomidine affected the upper esophageal sphincter with decreased pre- and post-swallow contractile pressures and an increase in residual pressure during swallow-related relaxation. On esophageal function, dexmedetomidine decreased contractile vigor of the proximal esophagus and increased velocity of the peristaltic contraction wave. Residual pressures during swallow-related esophagogastric junction (EGJ) relaxation decreased, as did basal EGJ resting pressure. The effects on the functional variables were not clearly dose-dependent, but mild subjective swallowing difficulties were more common at the higher dose level.

CONCLUSIONS AND INFERENCES: Dexmedetomidine induces effects on pharyngeal swallowing and esophageal motility, which should be considered in clinical patient management and also when a sedative agent for procedural sedation or for manometric examination is to be chosen.

Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2023. Vol. 35, no 1, article id e14501
Keywords [en]
Dexmedetomidine, esophageal motility, pulmonary aspiration, sedatives, swallowing function
National Category
Anesthesiology and Intensive Care
Identifiers
URN: urn:nbn:se:oru:diva-102538DOI: 10.1111/nmo.14501ISI: 000894029900001PubMedID: 36458525Scopus ID: 2-s2.0-85143893570OAI: oai:DiVA.org:oru-102538DiVA, id: diva2:1716317
Funder
Region Örebro CountyÖrebro University
Note

Funding agencies:

National Health and Medical Research Council (NHMRC) of Australia

University of Turku

Available from: 2022-12-05 Created: 2022-12-05 Last updated: 2023-04-21Bibliographically approved
In thesis
1. Risk of pulmonary aspiration during anesthesia and sedation
Open this publication in new window or tab >>Risk of pulmonary aspiration during anesthesia and sedation
2023 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Pulmonary aspiration is a feared complication in anesthesia practice. Even if it is a rare event it is the most common cause of anesthesia related death. There are two different types of pulmonary aspiration, macroaspirationwhere large amounts of gastric content are inhaled to the lungs, and the silent, often unnoticed, microaspiration, where small amounts of gastric or oropharyngeal contents are aspirated. Micro aspirations is much more common and can occur at any time during the perioperative period, presenting as postoperative pulmonary complications, often several days after the anesthesia procedure. 

Human physiology features multiple mechanisms of protection against pulmonary aspiration, including the esophageal sphincters that prevent gastric regurgitation and complex laryngeal reflex systems protecting the airway. An additional vital defense against pulmonary aspiration is an intact swallowing function, with dysphagia being the primary cause of aspiration pneumonia. Anesthetic agents affect these protective mechanisms to various extent.

The aim of this thesis was to study the effects of sedative agents on swallowing function, and different ventilatory techniques during anesthesia induction in healthy volunteers. In study I, the use of positive end expiratory pressure during mask ventilation after anesthesia induction was studied in regard of risk of gastric insufflation. In study II and IV the pharmacological effects of the opioid remifentanil on swallowing function were studied. Study III was the first study on effects of dexmedetomidine on human swallowing physiology. The experiments in this thesis has led to a deeper understanding in how different anesthetic agents affects the physiological protective mechanisms against pulmonary aspiration, both during anesthesia induction and sedation. The findings may facilitate clinical decisions, leading to better risk management in terms of macroaspiration during anesthesia and sedation, and postoperative pulmonary complications related to microaspirations.

Place, publisher, year, edition, pages
Örebro: Örebro University, 2023. p. 72
Series
Örebro Studies in Medicine, ISSN 1652-4063 ; 277
Keywords
Pulmonary aspiration, face-mask ventilation, anesthesia induction, high resolution impedance manometry, procedural sedation, remifentanil, dexmedetomidine, swallowing physiology
National Category
Surgery
Identifiers
urn:nbn:se:oru:diva-104355 (URN)9789175294957 (ISBN)
Public defence
2023-05-12, Örebro universitet, Campus USÖ, hörsal X1, Södra Grev Rosengatan 32, Örebro, 09:00 (Swedish)
Opponent
Supervisors
Available from: 2023-02-20 Created: 2023-02-20 Last updated: 2023-04-28Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Cajander, PerSavilampi, Johanna

Search in DiVA

By author/editor
Cajander, PerSavilampi, Johanna
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Neurogastroenterology and Motility
Anesthesiology and Intensive Care

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 357 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf